The historical rank and industry rank for Eckert & Ziegler SE's Net Margin % or its related term are showing as below:
CHIX:EUZd'
s Net Margin % Range Over the Past 10 Years
Min: 7.67 Med: 10.97 Max: 19.14
Current: 11.63
CHIX:EUZd's Net Margin % is ranked better than 76.13% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 0.73
vs CHIX:EUZd: 11.63
Eckert & Ziegler SE Net Margin % Historical Data
The historical data trend for Eckert & Ziegler SE's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eckert & Ziegler SE's Net Margin %
For the Medical Devices subindustry, Eckert & Ziegler SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE's Net Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Net Margin % distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eckert & Ziegler SE (CHIX:EUZd) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Eckert & Ziegler SE Net Margin % Related Terms
Thank you for viewing the detailed overview of Eckert & Ziegler SE's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:EUZD has been successfully added to your 